Styler MJ - Search Results

1

Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases.

Dezern AE, Styler MJ, Drachman DB, Hummers LK, Jones RJ, Brodsky RA. Dezern AE, et al. Among authors: styler mj. Am J Blood Res. 2013;3(1):84-90. Epub 2013 Jan 17. Am J Blood Res. 2013. PMID: 23358715 Free PMC article.

2

Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease.

Brodsky RA, Petri M, Smith BD, Seifter EJ, Spivak JL, Styler M, Dang CV, Brodsky I, Jones RJ. Brodsky RA, et al. Ann Intern Med. 1998 Dec 15;129(12):1031-5. doi: 10.7326/0003-4819-129-12-199812150-00007. Ann Intern Med. 1998. PMID: 9867758 Clinical Trial.

3

High-dose cyclophosphamide without stem-cell rescue for refractory CIDP.

Brannagan TH 3rd, Pradhan A, Heiman-Patterson T, Winkelman AC, Styler MJ, Topolsky DL, Crilley PA, Schwartzman RJ, Brodsky I, Gladstone DE. Brannagan TH 3rd, et al. Among authors: styler mj. Neurology. 2002 Jun 25;58(12):1856-8. doi: 10.1212/wnl.58.12.1856. Neurology. 2002. PMID: 12084892

4

High-dose cyclophosphamide for severe systemic lupus erythematosus.

Gladstone DE, Prestrud AA, Pradhan A, Styler MJ, Topolsky DL, Crilley PA, Hoch S, Huppert A, Brodsky I. Gladstone DE, et al. Among authors: styler mj. Lupus. 2002;11(7):405-10. doi: 10.1191/0961203302lu229oa. Lupus. 2002. PMID: 12195780 Clinical Trial.

5

Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: what is the optimal timing?

Ener RA, Meglathery SB, Cuhaci B, Topolsky D, Styler MJ, Crilley P, Brodsky I, Kahn SB, King RS. Ener RA, et al. Among authors: styler mj. Am J Clin Oncol. 2001 Feb;24(1):19-25. doi: 10.1097/00000421-200102000-00003. Am J Clin Oncol. 2001. PMID: 11232944

6

Topolsky D, Crilley P, Styler MJ, Bulova S, Brodsky I, Marks DI. Topolsky D, et al. Among authors: styler mj. Bone Marrow Transplant. 1996 Apr;17(4):549-54. Bone Marrow Transplant. 1996. PMID: 8722353

7

Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.

Styler MJ, Crilley P, Biggs J, Moul J, Copelan E, Topolsky D, Avalos B, Penza S, Sabol P, Downs K, Szer J, Brodsky I, Marks DI. Styler MJ, et al. Bone Marrow Transplant. 1996 Jul;18(1):171-6. Bone Marrow Transplant. 1996. PMID: 8832011

8

Transient high grade heart block following autologous bone marrow infusion.

Styler MJ, Topolsky DL, Crilley PA, Covalesky V, Bryan R, Bulova S, Brodsky I. Styler MJ, et al. Bone Marrow Transplant. 1992 Nov;10(5):435-8. Bone Marrow Transplant. 1992. PMID: 1464006

9

Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantation.

Crilley P, Topolsky D, Styler MJ, Bernstein E, Resnick K, Mullaney R, Bulova S, Brodsky I, Marks DI. Crilley P, et al. Among authors: styler mj. Bone Marrow Transplant. 1995 Mar;15(3):361-5. Bone Marrow Transplant. 1995. PMID: 7599559

10

Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.

Zak D, Styler MJ, Rosenbluth JZ, Brodsky I. Zak D, et al. Among authors: styler mj. Clin Adv Hematol Oncol. 2005 Apr;3(4):297-9; discussion 300-2. Clin Adv Hematol Oncol. 2005. PMID: 16167002 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page